POPULARITY
15 episodes with Valley of Death
6 episodes with Valley of Death
5 episodes with Valley of Death
4 episodes with Valley of Death
2 episodes with Valley of Death
3 episodes with Valley of Death
2 episodes with Valley of Death
2 episodes with Valley of Death
2 episodes with Valley of Death
Diren Kartal joins James Smith for an honest, often hilarious conversation about what running a small business actually does to you once the money is coming in but the freedom isn't. Diren is a personal trainer and Turkey's number one fitness coach with over 1.2 million followers, and despite bringing in hundreds of thousands a year he can't shake the feeling that none of it sticks. Together they unpick the tax trap that's bleeding British high-earners dry, the brutal "valley of death" stage of scaling, his secret ADHD diagnosis, and why the two of them keep eyeing the exits to Australia, Dubai and Turkey.
Comments/ideas: ACFpod@outlook.comSummer Bae from Cleantech Group joins us to reveal how the Asia Pacific cleantech market is finally moving from hype to solid business proof. We dive into the "two valleys of death" for hardware startups and the urgent need for catalytic capital to bridge the regional funding gap. We explore how AI accelerates hardware breakthroughs and why the global focus has shifted from net-zero targets to energy security and resilience. Professionals in climate finance and business will gain vital insights into navigating institutional roadblocks and scaling frontier innovation across APAC.Ref.: Cleantech Group, Global Cleantech 100 Report, APAC Cleantech 25 Report, ABOUT SUMMER. Summer Bae is the Managing Director, APAC at Cleantech Group and is based in Singapore. Prior to Cleantech Group, Summer spent over 10 years at BloombergNEF, where she built partnerships with financial institutions, governments, and corporations to advance sustainable finance and clean technology adoption across the region. She focused on developing strategic relationships with C-suite leaders, particularly in Korea, Japan, and ASEAN. Earlier in her career, Summer held regional sales and planning roles at Datum Alloys, covering markets across Asia, Europe, and the Americas. She began her career at Sumitomo Chemical, where she managed chemical production line operations and was involved in business planning. Summer holds a Bachelor's degree in Asia-Pacific Sociology from Ritsumeikan Asia Pacific University in Japan and earned the Sustainable Investing Certificate from the CFA Institute in 2025.Recommendations: Nat Bullard Annual Presentation: A data-rich and accessible slide deck that provides a comprehensive summary of global developments in climate, energy, and technology.2026 Cleantech Forum Asia, 2026 Cleantech Forum Europe, 2027 Cleantech Forum North America: Professional networking platforms and international conferences held in three continents to support the commercialisation of new technologies.Company list: #Bloomberg Finance L.P. (BloombergNEF), #Cleantech Group LLC, #Fervo Energy, Inc., #Halcyon (Halcyon Group Holdings LLC), #Sumitomo Chemical Co., Ltd.HOST, PRODUCTION, ARTWORK: Joseph Jacobelli | MUSIC: Ep76 onward excerpts from Vivaldi's La Follia, played by Luca Jacobelli.
"The challenge is not getting better biology. It's building a better system to carry the biology forward," says Richard van Rijnsoever.Debby Vermeer and Richard van Rijnsoever are co-founders of ExpediteBio, a Netherlands-based venture focused on accelerating antibody and protein therapeutics from discovery to first-in-human study. Debby also co-leads the biologics workstream at Oncode Accelerator, a national initiative working to accelerate cancer therapy development, e.g., by building infrastructure in the Netherlands.On the PharmaSource podcast, Debby and Richard spoke about the structural reasons biologics programs fail to reach patients, how their ASCEND framework addresses those failures, and what a more functional European biologics ecosystem could look like. Their conversation is a practical guide for biotech CEOs and CMC leaders navigating the most expensive stretch of early-stage drug development.Read more.
Krystal Clark & the Conditions at Women's Huron Valley prison... "THE VALLEY OF DEATH"This week on Turning A Moment Into A Movement, we confront one of the most urgent human rights crises happening behind prison walls.Join us for a powerful and necessary conversation:“Krystal Clark and the Conditions at Women's Huron Valley Prison… THE VALLEY OF DEATH.”As disturbing reports continue to surface surrounding medical neglect, environmental hazards, abuse, and the treatment of incarcerated women at Michigan's only women's prison, we ask the hard questions:How many warning signs have been ignored?How many voices have been silenced?And how many lives must suffer before accountability finally comes?This conversation will shine a light on the conditions inside Women's Huron Valley Correctional Facility, the ongoing fight for justice for Krystal Clark, and the broader issues impacting incarcerated women across this country.This is more than a conversation — it's a call to action....with our guest: Dr. Shawanna Vaughn Founder and CEO of Silent Cry (non-profit). Silent Cry, IncStay informed. Stay engaged. Stay powerful.To learn more about Krystal Clark: fightingforkrystalclark Official: TikTok, Instagram, Facebook | Linktree***Turning A Moment Into A Movement Podcast MISSION:To bring awareness, organize, and create content that will be a resource that will aide families, communities, and those seeking Justice for WRONGFUL CONVICTIONS and Injustice. ...and advocating for Justice & Exoneration for GERARD HAYCRAFT. www.change.org/Justice4GerardTurning A Moment Ino A Moment Team:-Jay Love Host: Founder and Creator of Turning A Moment Into A Movement, The Justice for Gerard Movement, to learn more about The Justice for Gerard Movement go to: www.change.org/Justice4GerardExecutive Board member of Michigan Coalition of Human Rights, G100 Prison Reforms & Reintegration Global Advisory Council Member-Rev. Tia Littlejohn: Behavioral Therapist, Founder of the Choice Zone, G100 Global Chair G100 Prison Reforms & Reintegration, Co-Chair & Executive Board member of Michigan Coalition of Human Rights, Author, www.thechoicezone.com-Trische' Duckworth: Executive Director/Founder of Survivors Speak, Founder/ Lead Consultant of Value Black Lives, Social Worker, Justice Advocate, Board member of Michigan Coalition of Human Rights,https://www.survivorsspeak.infoTo learn more about Turning A Moment Into A Movement:https://linktr.ee/turningamomentintoa...
The bloody fight against Rocky Mountain Spotted Fever continues and concludes. Check out: indeed.com/theconstant now to start hiringVisit our Patreon here. You too can get ad-free, early episodes, starting now!BUY OUR MERCH, YOU FILTHY ANIMALS! The Constant is part of the Airwave Media podcast network.Interested in advertising on The Constant? Email sales@advertisecast.com to get on board! Learn more about your ad choices. Visit megaphone.fm/adchoices
Here's a change: a history of getting something RIGHT. Eventually. Check out: indeed.com/theconstant now to start hiringVisit our Patreon here. You too can get ad-free, early episodes, starting now! BUY OUR MERCH, YOU FILTHY ANIMALS! The Constant is part of the Airwave Media podcast network. Interested in advertising on The Constant? Email sales@advertisecast.com to get on board! Learn more about your ad choices. Visit megaphone.fm/adchoices
The transition from a cleared medical device to a commercialized product is one of the most perilous phases for a MedTech startup. While founders frequently anticipate the technical and regulatory hurdles of early-stage development, they often underestimate the "commercial valley of death." Success in the modern healthcare economy requires more than a functional prototype and clinical validation; it requires an exact blueprint to navigate the complex organizational structures of health systems, ambulatory surgery centers, and value analysis committees.A primary pitfall for early-stage innovators is the discrepancy between clinical data expectations and real-world market entry. Founders naturally possess an unwavering belief in their technology to secure funding, yet this can inadvertently lead to an overestimation of rapid adoption and an underestimation of institutional purchasing complexity. Mitigating this pressure requires integrating strategic commercial leadership early in the timeline—often months prior to receiving regulatory clearance—to properly align the market profile and build institutional momentum before the product officially launches.Choosing the right commercial framework depends heavily on the disruptive nature of the device itself. While traditional hiring mechanisms or independent distributors can be effective for incremental or transactional product categories, highly disruptive technologies and high-ticket capital equipment demand a deeper, more execution-focused partnership. Implementing a modern, fractional commercial model provides seed-stage companies with a capital-efficient method to engage veteran industry strategics, reassure investors, establish clear operational ROI for hospital administrators, and build a lasting culture of advocacy within clinical environments.Key Timestamps00:01 – Introduction to the Commercial Valley of Death: Etienne Nichols introduces guest Ryan O'Mahoney and redefines the "valley of death" as the treacherous phase spanning prototyping, global scaling, and institutional market adoption.03:24 – The Underestimation vs. Overestimation Trap: Analysis of why clinical data optimism can lead to inflated forecasting and a failure to anticipate the procedural gauntlet of modern hospital purchasing.04:51 – Optimal Timing for Commercial Integration: When founders should bring on commercial expertise, highlighting why a few months prior to FDA clearance is the ideal window to build momentum.07:41 – Investor and Strategic Benefits: How early commercial positioning signals stability to venture capitalists, enhances company valuations, and opens doors for strategic corporate exits.10:03 – Go-To-Market Frameworks Compared: A breakdown of traditional full-time hiring, utilizing independent consultants, and leveraging distribution networks, alongside the risks and benefits of each.13:16 – The Rise of Modern Fractional Commercial Models: Exploring the hybrid approach as a capital-preserving mechanism designed for maximum impact on initial adoption.15:06 – The Three Non-Negotiable Pillars of Adoption: Introduction of the foundational framework required to pass go: clinical superiority, technical clinician enhancement, and administrative return on investment.18:59 – Escaping Perpetual Pilot Programs: Strategies to convert early clinical interest and hospital trials into concrete, multi-million dollar purchase orders.22:30 – Navigating Value Analysis and Hospital Budgets: How to pivot the conversation from purely clinical superiority to operational and economic ROI for healthcare administration.25:27 – Recruiting and Managing High-Intellect Commercial Teams: Building an organizational culture centered around purpose, passion, and retaining the founding team as an inspirational backbone.Quotes"They underestimate the complexity of introducing the technology and actually getting it through the gauntlet of introduction to whether it's individual hospitals, health systems, ambulatory surgery centers, or even privately owned labs and institutions." — Ryan O'Mahoney"In this modern day, and the economic climate, and the power that administration has... the clinical is not enough." — Ryan O'MahoneyTakeawaysCommercial StrategyEngage Commercial Strategy Pre-Clearance: Begin structuring your commercial roadmap and refining your Ideal Customer Profile (ICP) 2 to 3 months before expected regulatory clearance to ensure your go-to-market execution launches seamlessly.Capital Allocation & FundraisingLeverage Fractional Expertise to De-Risk Valuation: Utilizing fractional commercial executives preserves vital runway while instilling institutional confidence in investors, signaling that the organization is prepared for real-world scaling.R&D & Product AlignmentPass the Three-Pillar Framework Before Scaling: Ensure your technology satisfies all three essential vectors before attempting commercial scale: measurable clinical differences for the patient, procedural advantages over the status quo for the practitioner, and clear economic return on investment for the administration.Market DevelopmentPre-Align Administration to Avoid Broken Pilots: Prevent your device from getting stuck in perpetual, non-revenue-generating clinical trials by engaging hospital administrators in virtual demonstrations early, tying the success metrics of the pilot directly to a formal budget proposal pathway.ReferencesCatalyst Ventures: The commercial acceleration and strategy firm founded by Ryan O'Mahoney, specializing in bringing paradigm-shifting medical technologies to global markets.Etienne Nichols: Connect with the host on LinkedIn via Etienne Nichols' LinkedIn Profile.MedTech 101 SectionThe Valley of Death (Commercialization)In the medical device space, engineers often look at the "valley of death" as the difficult phase of raising money to move from a prototype to regulatory submission. However, there is a second commercial valley of death. This is the period after you get your official clearance from regulatory bodies (like the FDA), where companies frequently run out of money because they cannot figure out how to navigate complex hospital networks, get approved by purchasing committees, and turn clinical interest into consistent sales revenue.Value Analysis Committee (VAC)Think of a hospital's Value Analysis Committee as a strict gatekeeper panel for the hospital's wallet. Years ago, if a doctor liked a medical tool, the hospital bought it. Today, a formal committee made up of administrators, finance staff, and doctors must review every new product. They analyze whether the device is truly better than what they already use, if it reduces hospital stay times, and if the financial cost makes sense against the hospital's annual budget.Feedback Call-to-ActionWe want to hear from you. Have you encountered the commercial valley of death in your own medical device journey? Do you have specific regulatory, commercial, or operational topics you want us to unpack in upcoming episodes?Drop us a line at podcast@greenlight.guru with your thoughts, questions, or guest recommendations. We read every email and look forward to delivering the personalized insights you need to confidently bring your innovations to life.SponsorsThis episode of the Global Medical Device Podcast is brought to you by Greenlight Guru, the only dedicated medical device success platform. Moving successfully from innovation through the commercial gauntlet requires total synchronization across your entire lifecycle. Greenlight Guru's modern Quality Management Software (QMS) ensures your documentation, design controls, and regulatory submittals remain audit-ready and airtight during pre-market development.Once cleared, seamlessly transition your clinical data collection into the real world using Greenlight Guru's Electronic Data Capture (EDC) solutions. Together, their QMS and EDC ecosystem empowers MedTech startups to de-risk their commercialization process, satisfy demanding institutional purchasing committees, and scale safely worldwide. Learn more at www.greenlight.guru.
Re-Run arrives and struggles to assimilate into the family for the next twenty years. Lucy is still a grouch. Sally still loves Linus. And speaking of consistency, which Peanuts characters changed the least? The gang investigates. Transcript available at UnpackingPeanuts.com Jimmy's, Michael's, and Harold's books are available at UnpackingPeanuts.com/store. Unpacking Peanuts is copyright Jimmy Gownley, Michael Cohen, Harold Buchholz, and Liz Sumner. Produced and edited by Liz Sumner. Music by Michael Cohen. Additional voiceover by Aziza Shukralla Clark. For more from the show follow @unpackpeanuts on Instagram and Threads, and @unpackingpeanuts on Facebook, Blue Sky, and YouTube. For more about Jimmy, Michael, and Harold, visit unpackingpeanuts.com. Thanks for listening.
Why do the most operationally excellent directors get passed over for VP roles? The vice presidency is not an award for hard work but a fundamental migration in how you lead. Discover more about Dr. Grace's Mastery Accelerator mentorship and speak with one of her career advisors here: https://masteryinsights.com/mentorship-pc What is the SCALE Framework? The SCALE Framework is a system of operating laws designed to guide the transition from Director-level execution to VP-level leadership. It redefines how leaders create value by shifting their focus from managing functional output to governing enterprise systems. Instead of prioritizing short-term execution, it equips leaders to think in terms of capital allocation, cross-functional trade-offs, and long-term value creation. The framework is composed of five pillars: System Authority, Create Commercial Value, Alter the Wealth Ecosystem, Leverage Cross-functional Capital, and Embody Appropriate Presence. Key Concepts System Authority: VPs are accountable for enterprise-wide coherence, managing cross-functional dependencies, trade-offs, and second-order effects beyond their immediate function. Commercial Bilingualism: The ability to translate technical expertise into business impact, clearly articulating how decisions affect revenue, cost, and profitability. The Mirror of Personal Finance: A leader's relationship with risk, investment, and money in their personal life reflects their ability to make high-stakes business decisions. Wealth Ecosystem Construction (Niche Construction): VPs build environments that generate long-term value, resilience, and talent attraction rather than simply operating within existing systems. Gravitational Presence: Leadership at the VP level is defined by clarity, weight, and alignment, in contrast to the execution-driven, high-motion presence required at the Director level. There is a clear line between those who stay at Director level and those who move up. Where do you currently stand? Comment below with your perspective. Show notes and free resources: https://CareerRevisionist.com/episode238 Do you want to move up in executive leadership? Want to elevate your communication skills, leadership abilities and influence in the world around you? If you're ready to start leveling up in your career and you want to develop all of the skills and professional acumen that will allow you to grow into senior executive positions with confidence, apply here: https://masteryinsights.com/mentorship-pc Answer a few questions to see if you qualify for Dr. Grace's executive coaching program, then book a time to speak with a member of our team. --------- Thank You for Listening! I am truly grateful that you have chosen to tune in. Visit my Youtube channel where I release new videos weekly on executive career growth, communication, increasing income, and professional development. Please share your thoughts! Leave questions or feedback in the comments below. Leave me a review on iTunes and share my podcast with your colleagues. With Love & Wisdom, Grace
In this episode, host Etienne Nichols sits down with Dr. Adam Saltman, Chief Medical Officer at NAMSA, to explore the treacherous "valley of death" that exists between a medical device prototype and the patient. With a unique "triple threat" perspective as a cardiothoracic surgeon, former FDA official, and industry consultant, Dr. Saltman reveals why technical brilliance often fails in the face of commercial reality.The conversation dives deep into the common pitfalls of early-stage startups, specifically the tendency to develop technology in a "tech echo chamber" without validating the unmet clinical need. Dr. Saltman shares a sobering story of a company that achieved regulatory authorization and reimbursement only to find that no one wanted to buy their product because it solved a problem clinicians didn't have.Finally, the discussion shifts to the evolving landscape of AI in healthcare. Dr. Saltman warns against "automation bias" and emphasizes that regulators and clinicians are no longer satisfied with "black box" explanations. Whether it's navigating FDA guidance or choosing between a 510(k) and a De Novo pathway, the takeaway is clear: start with the end user in mind and validate every hypothesis with real-world clinical perspective.Key Timestamps[00:01:45] Introducing Dr. Adam Saltman: The surgeon, regulator, and consultant perspective.[00:03:10] The #1 Mistake: Building a product that doesn't address an actual unmet clinical need.[00:05:40] The Echo Chamber: Why engineers must look beyond their own circles for product validation.[00:06:50] The CFO vs. The Surgeon: A cautionary tale about who actually makes the purchasing decisions in a hospital.[00:09:40] Staying Current: How to manually and digitally track the constant stream of FDA guidance documents.[00:11:45] AI in MedTech: Moving from "black box" algorithms to transparent, explainable technology.[00:13:30] The X-Ray Failure: A real-world example of AI predicting mortality based on patient location rather than clinical data.[00:15:20] Automation Bias: Why you should treat AI as an assistant, not a replacement.[00:18:15] Marketing vs. Utility: The "Billboard Effect" of surgical robots and AI features.[00:20:00] Signs of Success: How Dr. Saltman identifies startups that are likely to succeed versus those "wasting" capital.[00:23:10] Calling the Baby Ugly: The necessity of pivot-readiness and adult influence in startup management.[00:25:30] The 510(k) Trap: Why the fastest regulatory path might be your biggest commercial hurdle.Quotes"You really need to start with the end in mind and test that hypothesis. Get out of the office and go out there and talk to people and really confirm that." - Dr. Saltman"This is my assistant, not my replacement." - Dr. SaltmanTakeawaysValidate the Unmet Need: Before investing in R&D, ensure your target customer actually sees a need for the product. Technical viability does not equal market demand.Avoid the 510(k) Trap: Opting for the easiest regulatory path may pigeonhole your device into low reimbursement codes by labeling it as "the same" as existing technology.Combat Automation Bias: Never assume an AI or automated system is 100% correct. Maintain a critical eye and perform regular "smell tests" on AI-generated outputs.Engage Clinical Input Early: It is almost impossible to get professional clinical input too early, but it is very easy to seek it too late. Consider fractional clinical leadership to save costs.Identify All Stakeholders: Your user (the surgeon or nurse) is often not the purchaser (the CFO). Your evidence strategy must satisfy both.ReferencesZotero: A free reference manager Dr. Saltman uses to track and tag FDA guidance documents.The Founder's Dilemma: A book referenced regarding the challenges of early-stage startup management and decision-making.Etienne Nichols' LinkedIn: Connect with Etienne here.MedTech 101 Section: The 510(k) vs. De NovoThink of a 510(k) like a "Me Too" application. You are telling the FDA, "My device is just like this other one already on the market (the predicate)." It's usually faster and cheaper. A De Novo is for "New" territory—devices that are low-to-moderate risk but don't have a direct twin already on the market. While 510(k) is the path of least resistance, it can be a "trap" because it makes it harder to argue that your device is unique enough to deserve a higher price or better insurance coverage.Feedback Call-to-ActionWe want to hear from you! Do you have a MedTech success story or a regulatory hurdle you're currently facing? Send your feedback, reviews, and topic suggestions to podcast@greenlight.guru. We read every email and love providing personalized responses to our community of innovators.SponsorsThis episode is brought to you by Greenlight Guru. When navigating the "valley of death" between prototype and patient, you need a robust ecosystem to manage your data. Greenlight Guru offers industry-leading QMS (Quality Management Software) to keep your compliance on track and EDC (Electronic Data Capture) solutions to ensure your clinical evidence is ironclad. Whether you're avoiding the 510(k) trap or preparing for a De Novo submission, Greenlight Guru helps you close the gap with confidence.
Fervo landed a large new loan with terms that strongly suggest the company's most turbulent days are behind it. Also, K2's Gravitas is an ambitious project that aims to demonstrate the tech needed to build data centers in space. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Nintendo surged 18% in 2 weeks thanks to 30-year old Pokemon… and it hates AI.Quince just hit a valuation twice as good as Skims… thanks to caviar, candles, and caviar?Rivian is taking orders for the R2… which has to disrupt Rivian, and save Rivian.And the Academy Awards have a shocking plan for last night's Red Carpet… Destroy it.$NTDOY $RIVN $DUPEBuy tickets to The IPO Tour (our In-Person Offering) TODAYNew York, NY (4/8): https://www.ticketmaster.com/event/0000637AE43ED0C2Los Angeles, CA (6/3): SOLD OUTGet your TBOY Yeti Doll gift here: https://tboypod.com/shop/product/economic-support-yeti-doll NEWSLETTER:https://tboypod.com/newsletter OUR 2ND SHOW:Want more business storytelling from us? Check our weekly deepdive show, The Best Idea Yet: The untold origin story of the products you're obsessed with. Listen for free to The Best Idea Yet: https://wondery.com/links/the-best-idea-yet/NEW LISTENERSFill out our 2 minute survey: https://qualtricsxm88y5r986q.qualtrics.com/jfe/form/SV_dp1FDYiJgt6lHy6GET ON THE POD: Submit a shoutout or fact: https://tboypod.com/shoutouts SOCIALS:Instagram: https://www.instagram.com/tboypod TikTok: https://www.tiktok.com/@tboypodYouTube: https://www.youtube.com/@tboypod Linkedin (Nick): https://www.linkedin.com/in/nicolas-martell/Linkedin (Jack): https://www.linkedin.com/in/jack-crivici-kramer/Anything else: https://tboypod.com/ About Us: The daily pop-biz news show making today's top stories your business. Formerly known as Robinhood Snacks, The Best One Yet is hosted by Jack Crivici-Kramer & Nick Martell. Hosted on Acast. See acast.com/privacy for more information.
Send a textSupport the show· Our Website is: xrecruiter.io
Almost every growing business experiences a moment when success starts creating as many problems as it solves. Sales are up. The team is bigger. The product line is broader. And suddenly, the systems that got you here start to break. That's where Liz Picarazzi finds herself right now. “We're in the valley of death,” she says. “And we really need help.” Liz's company, Citibin, made the most recent Inc. 5000 list, but Citibin has also hit that dangerous in-between stage—too big to run on improvisation, too small to have put in place all of the processes it needs.So Liz is trying to grow her way out of the valley. She's hired a marketing agency. A growth consultant. And two AI advisors. She's testing new domestic fabricators. And she's rebuilding her website from the ground up—because right now, it's generating no more than 10 percent of sales, and she knows it can do better. The site hasn't kept up with her expanding product line, and it isn't even optimized for search engine discovery, let alone for generative AI discovery.Talking it through with Paul Downs and Jaci Russo, Liz confronts some uncomfortable questions: How much copy is “enough” for AI? How transparent should pricing be—especially for a premium product whose prices could scare away some customers? And who has a better feel for the company's story—the owner who's lived it or the agency that has more experience helping businesses connect with customers? Not surprisingly, Liz and Jaci have different instincts on that one. What follows is a candid look at what it takes to rebuild a growing business at the dawn of a new era.
TODAY'S TREASUREEven though I walk through the valley of the shadow of death, I will fear no evil, for you are with me; your rod and your staff, they comfort me. Psalm 23:4 ESVSend us a comment!Support the show
Beyond moves happening on the stock front, Michael Green offers his perspective on the FOMC and potential rate cuts in December and beyond. When it comes to measuring inflation, he says the CPI has problems that don't paint the whole story for investors. Michael later explains the "valley of death" he sees plaguing consumers. ======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – / schwabnetwork Follow us on Facebook – / schwabnetwork Follow us on LinkedIn - / schwab-network About Schwab Network - https://schwabnetwork.com/about
The Pentagon's tech pipeline is littered with promising innovations that never make it to the field. MITRE's new Transition Maturity Framework aims to change that by replacing the slow, siloed acquisition process with a collaborative, data-driven approach. For insight on how this framework could help warfighters—and why it might be a fix for the “ditches of death”—we turn to MITRE's senior vice president for national security, Keoki Jackson.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
God is our good shepherd who knows us by name and pursues us with love. Join us this morning as Zach W. Lambert walks us through David's story!We live-stream every Sunday at 9:30am CT. If you'd like to connect with Restore, go to www.restoreaustin.org/connect.Resources Referenced:The Jewish Study BibleThe NIV Cultural Backgrounds Study Bible
Jamie Daggett started his career as a mechanical engineer working for cleantech startups in Silicon Valley. But after five startups and three buyouts, Daggett saw the same story repeat itself: good technologies that worked in the lab often died before reaching commercial scale. And often they didn't fail because the science was wrong; they failed because investors couldn't trust that the performance would hold up over time. That realization eventually led him to an unexpected place: insurance. Today, Daggett is the energy storage and fuel cell lead at Ariel Green, a Lloyd's of London syndicate that provides a wide range of insurance for clean-energy projects. “Insurance is another tool that we can use to help grow the clean-energy market,” says Daggett. “I do feel like it plays an unsung role behind the scenes.” In this episode, produced in collaboration with Ariel Green, Daggett talks with Stephen Lacey about how insurance is helping the energy storage sector mature. They discuss how the bankruptcy of Powin Energy exposed the fragility of supplier warranties, what the Moss Landing fire revealed about chemistry and safety risk, and how new markets for long-duration and non-lithium storage are testing the boundaries of what can be insured. Daggett explains how technology performance insurance now allows lenders, developers, and manufacturers to move faster by transferring risk from young suppliers to a creditworthy insurer. This is a partner episode, produced in collaboration with Ariel Green. Ariel Green helps clients reduce uncertainty by providing investment-grade insurance for clean-energy projects — protecting the technologies that protect the environment. To learn more, visit arielgreen.com.
Johan och Roger träffas för att fira att Roger precis har fyllt 18 år och blivit myndig! (Ja, i nykterheten alltså). Vi kommer osökt in på the Valley of death - den där lilla fasen mellan 10 och 20 års nykterhet. Vi diskuterar vikten av att gå på möten även efter lång tid i nykterheten, för att visa att programmet funkar. Vi balanserar denna hybris med vikten av att lyssna på nya i programmet - för att vi ska komma ihåg hur det var och kanske lära oss något i processen. På det temat så inser vi att vi lär oss nya saker hela tiden genom att gå på möten. Johan pratar om New York, vikten av gemenskap även där. Att ha programmet nära även när man är långt borta och att man inte behöver känna sig ensam bara för att man är själv. Tack för att ni lyssnade även denna vecka kära lyssnare! Kram från Johan och Roger.
The “Valley of Death” has become a popular term to describe a challenging period for sustainability focused startups. Bridging this “valley of death” in commercialization of sustainable technologies is a key role today's guest believes her company can play for their clients. Cindy Jia is Head of the Sustainable Solutions Group at ING Capital. Her goals for the ING team include accelerating adoption of sustainable tech and facilitating an easy transition between the different capital pools that are available. Today we're going to discuss the challenges in achieving these goals and how ING has progressed.
Series: Psalm 23Sermon Title: Valley of Death (Part 3)Main Scripture: Psalm 23:4 "Even though I walk through the valley of the shadow of death, I will fear no evil, for you are with me"Synopsis: For a second week in a row we are taking time to hear testimonies of God's faithfulness from those who have faced valleys of deep darkness and are still following their Shepherd. *praying for infertility *praying for long-term diagnosisSeptember 14, 2025 • Kyle Smith• • • • • • • •.• • • • • • • • • • • • • • • • • • • • Join us for service in person and online every Sunday at 10am (MST) at the City Life Community Center in Missoula, MT. We believe that you matter. We would love to connect with you and hear your story! https://www.anchorchurchmissoula.com/contactIf you would like to engage financially with Anchor Church you can give by texting any amount to 84321 or by visiting https://www.anchorchurchmissoula.comNeed prayer or have a praise report? https://www.anchorchurchmissoula.com/prayerpraiseFor more information about Anchor Church or ways to get connected visit us at https://www.www.anchorchurchmissoula.com or follow us on our social media platforms below.Instagram - @anchorchurchmissoula - https://www.instagram.com/anchorchurchmissoulaFacebook - @anchorchurchmissoula - https://www.facebook.com/anchorchurchmissoula
Series: Psalm 23Sermon Title: Valley of Death (Part 2)Main Scripture: Psalm 23:4 "Even though I walk through the valley of the shadow of death, I will fear no evil, for you are with me"Synopsis: In this message, we hear testimonies of the faithfulness of God from those who have been in the darkest of valleys. Let your faith be stirred by those who have faced the valley of the shadow of death, but are still walking and following the ShepherdSeptember 7, 2025 • Kyle Smith• • • • • • • •.• • • • • • • • • • • • • • • • • • • • Join us for service in person and online every Sunday at 10am (MST) at the City Life Community Center in Missoula, MT. We believe that you matter. We would love to connect with you and hear your story! https://www.anchorchurchmissoula.com/contactIf you would like to engage financially with Anchor Church you can give by texting any amount to 84321 or by visiting https://www.anchorchurchmissoula.comNeed prayer or have a praise report? https://www.anchorchurchmissoula.com/prayerpraiseFor more information about Anchor Church or ways to get connected visit us at https://www.www.anchorchurchmissoula.com or follow us on our social media platforms below.Instagram - @anchorchurchmissoula - https://www.instagram.com/anchorchurchmissoulaFacebook - @anchorchurchmissoula - https://www.facebook.com/anchorchurchmissoula
This episode's Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow' Sustainability Campaign, and how you can get involved: CLICK HEREEpisode Overview: Healthcare investment banking has long followed a volume-driven, cookie-cutter model that prioritizes transactions over transformative outcomes. Our next guest, Sam Libby, is changing that paradigm as founder and President of TCB Capital Advisors. With over 30 transactions totaling more than $20 billion, Sam brings a mission-driven approach to underinvested healthcare areas like oncology, women's health, and neurodegenerative diseases. After experiencing healthcare's systemic inefficiencies firsthand during his own patient journey, Sam founded TCB to reject traditional banking models in favor of long-term partnerships that embed early with management teams. His unique three-vertical approach combines banking expertise, clinical advisory, and commercial operations to drive both patient impact and financial success. Join us to discover how Sam's stewardship mindset is empowering healthcare pioneers to scale life-changing innovations. Let's go!Episode Highlights:Patient-First Philosophy: Sam emphasizes that healthcare professionals are "stewards that owe an obligation to the patient," maintaining focus on improving lives rather than just financial returns.Three-Vertical Approach: TCB Capital Advisors uniquely combines banking services, clinical/scientific advisory, and commercial operations to provide comprehensive support beyond traditional investment banking.Underinvested Healthcare Focus: The firm specifically targets neglected areas like oncology screening, neurodegenerative diseases, and women's health where innovation lags despite significant patient need.Real-World Patient Journey Experience: Sam's personal 10-month journey to reach a memory center despite having concierge care and good insurance highlighted systemic healthcare accessibility issues.Predictive Medicine Future: Sam sees AI-powered prognostic tools like Clarity's breast cancer risk assessment as the most promising innovation for identifying high-risk patients earlier and improving outcomes.About our Guest: Sam Libby is the founder and President of TCB Capital Advisors, a firm he created to help healthcare companies scale their impact through strategic transactions and long-term growth planning. With a career spanning roles at premier firms like Piper Sandler and Ziegler, Sam brings deep expertise in M&A, capital markets, and private placements, having completed more than 30 deals totaling over $20 billion in transaction value.Known for his hands-on, partner-oriented approach, Sam works closely with management teams to not only execute transactions but to position companies for enduring success. He has a particular focus on underinvested areas of healthcare—including oncology, women's health, and neurodegenerative disease—and is passionate about supporting founders building scalable solutions with real-world impact.Sam holds degrees in Finance and Accounting from Rutgers University, graduating summa cum laude.Links Supporting This Episode: TCB Capital Advisors Website: CLICK HERESam Libby LinkedIn page: CLICK HERETCB Capital AdvisorsLinkedIn: CLICK HEREMike...
Frontier tech startups don't fail because the science is bad — they fail because no one needs what they're building. In this episode, Roadrunner Venture Studios CEO/co-founder Adam Hammer explains how to avoid that fate. We talk about why the U.S. struggles to turn research into startups, why being right isn't enough, and what it really takes to cross the Valley of Death between lab science and real-world demand. Along the way, Adam shares practical insights for first-time founders, including: How to test whether your problem is painful enough to sell What the studio model offers that VCs and accelerators can't Why most technical founders struggle with pitching — and how to fix it And what scientists need to unlearn to become CEOs If you're building something deep, hard, or new — don't skip this one. RUNTIME 41:11 EPISODE BREAKDOWN (2:32) How a career spanning national labs, venture capital, and startup leadership led to Roadrunner Venture Studios. (7:46) “ Our goal is to compress all the mistakes that you would make in a three-year period into a year.” (8:50) The three frontier tech sectors Roadrunner focuses on: advanced energy, advanced manufacturing, and advanced compute. (10:28) Why it's so hard to translate lab science into sustainable, venture-scale businesses. (13:49) Adam shares ideas for bridging America's structural gap in commercializing frontier tech. (16:38) “ Roadrunner serves as a de-risking mechanism for ideas and for people.” (21:12) “ In science, you win by being right. But in startups, you win by being useful.” (24:23) What Adam looks for in a pitch deck. (27:15) When it comes to sourcing founders and ideas, “ we are as early as it gets.” (31:54) Why Roadrunner Venture Studios set up shop in New Mexico. (34:16) If he could fix one common founder misconception, what would it be? (36:26) “ There's nothing innate that predetermines whether somebody can or cannot be a founder.” LINKS Adam Hammer Roadrunner Venture Studios The Engine Overcoming the Valley of Death: A New Model for High Technology Startups SUBSCRIBE
Series: Psalm 23Sermon Title: Valley of Death (Part 1)Main Scripture: Psalm 23:4 "Even though I walk through the valley of the shadow of death, I will fear no evil, for you are with me;"Synopsis: To be human means experiencing seasons of valleys of death. Whether it is the grief of losing a loved one, a diagnosis, heartbreak, or some other form of loss or tragedy, we all will face valleys. However, our ability to endure the valleys is determined by the hope we have in our destination and our closeness to our Shepherd.August 24, 2025 • Kyle Smith• • • • • • • •.• • • • • • • • • • • • • • • • • • • • Join us for service in person and online every Sunday at 10am (MST) at the City Life Community Center in Missoula, MT. We believe that you matter. We would love to connect with you and hear your story! https://www.anchorchurchmissoula.com/contactIf you would like to engage financially with Anchor Church you can give by texting any amount to 84321 or by visiting https://www.anchorchurchmissoula.comNeed prayer or have a praise report? https://www.anchorchurchmissoula.com/prayerpraiseFor more information about Anchor Church or ways to get connected visit us at https://www.www.anchorchurchmissoula.com or follow us on our social media platforms below.Instagram - @anchorchurchmissoula - https://www.instagram.com/anchorchurchmissoulaFacebook - @anchorchurchmissoula - https://www.facebook.com/anchorchurchmissoula
Original Air Date: October 16, 1950Host: Andrew RhynesShow: The Lone RangerPhone: (707) 98 OTRDW (6-8739) Stars:• Brace Beemer (Lone Ranger)• John Todd (Tonto) Writer:• Fran Striker Producer:• George W. Trendle Music:• Ben Bonnell Exit music from: Roundup on the Prairie by Aaron Kenny https://bit.ly/3kTj0kK
Original Air Date: October 16, 1950Host: Andrew RhynesShow: The Lone RangerPhone: (707) 98 OTRDW (6-8739) Stars:• Brace Beemer (Lone Ranger)• John Todd (Tonto) Writer:• Fran Striker Producer:• George W. Trendle Music:• Ben Bonnell Exit music from: Roundup on the Prairie by Aaron Kenny https://bit.ly/3kTj0kK
The “Valley of Death” has become a popular term to describe a challenging period for sustainability focused startups. Bridging this “valley of death” in commercialization of sustainable technologies is a key role today's guest believes her company can play for their clients. Cindy Jia is Head of the Sustainable Solutions Group at ING Capital. Her goals for the ING team include accelerating adoption of sustainable tech and facilitating an easy transition between the different capital pools that are available. Today we're going to discuss the challenges in achieving these goals and how ING has progressed.
Canada wants to position itself as a leader in the critical mineral industry, as the world becomes more reliant on renewable energy. But its young mining companies are struggling, due to a mix of factors including changes to the local investment landscape, heavy restrictions on money from Chinese investors and, according to some industry insiders, excessive red tape. The struggle is particularly acute for mining companies in the middle stages of development, which is known in the industry as the “valley of death.”The Globe's mining reporter Niall McGee breaks down why companies are sounding the alarm, and what it means for Canada's future in the industry. Questions? Comments? Ideas? Email us at thedecibel@globeandmail.com
Jeremy Au discussed three key insights on Southeast Asia venture capital. First, he highlighted the "Series B Valley of Death," where local funds support pre-seed to Series A, and global investors focus on later stages, but Series B and C funding gaps force startups into aggressive cost-cutting or revenue expansion. Second, he emphasized the importance of timing in venture bets, arguing that startups must be positioned in the right economic window—neither too futuristic nor too late—illustrating with examples like AI-driven call centers in the Philippines and Vietnam's emerging luxury goods market. Third, he discussed how VCs balance two roles—judging founder potential and adding value—to maximize the likelihood of building unicorns - where startups adapt and learn quickly using the Lean Startup and OODA loops, with examples from sectors like HR tech, AI call centers, and consumer goods. Watch, listen or read the full insight at https://www.bravesea.com/blog/series-b-valley-of-death Get transcripts, startup resources & community discussions at www.bravesea.com WhatsApp: https://whatsapp.com/channel/0029VakR55X6BIElUEvkN02e TikTok: https://www.tiktok.com/@jeremyau Instagram: https://www.instagram.com/jeremyauz Twitter: https://twitter.com/jeremyau LinkedIn: https://www.linkedin.com/company/bravesea English: Spotify | YouTube | Apple Podcasts Bahasa Indonesia: Spotify | YouTube | Apple Podcasts Chinese: Spotify | YouTube | Apple Podcasts Vietnamese: Spotify | YouTube | Apple Podcasts
I sat down with Philip Bahoshy, founder of MAGNiTT, for a no-holds-barred conversation on the realities of the startup world. We unpack the "Startup Valley of Death," exploring why founders fail, when to quit, and how to navigate burnout. Philip dives into M&A challenges, scarce exits, and the rising role of secondary transactions and IPO readiness. He also highlights scaling hurdles in fragmented markets, the talent crunch, and UAE-Saudi ecosystem dynamics. With sharp predictions for 2025—AI's rise, more IPOs, and deeper ties with Southeast Asia—this episode offers critical insights for founders and investors navigating today's uncertain venture landscape.
In this conversation, Chad Prinkey, Founder and CEO of Well Built Construction Consulting, discusses the significant challenges faced by construction companies, including financial pressures, the importance of effective leadership, and the transition from owner-operated to process-driven businesses. He emphasizes the need for empowering teams, creating standard operating procedures, and fostering a positive company culture to ensure sustainable growth and success in the industry.TakeawaysThe construction industry is challenging and financially demanding.Many contractors face the risk of profits disappearing due to unforeseen circumstances.Empowering team members is crucial for reducing owner workload.The “valley of death” refers to the transition from owner-operated to process-driven businesses.Standard operating procedures are essential for scaling a business effectively.Company culture significantly impacts employee behavior and performance.Most employees are average and companies should create environments for them to thrive.Growth should be approached cautiously, ensuring readiness to handle new challenges.Effective communication and clear expectations are vital for team success.Consultants can help businesses navigate their growth and operational challenges.Chapters02:58 Navigating Financial Pressures in Construction06:08 Empowering Leadership and Team Dynamics08:58 The Valley of Death: Transitioning to a Scalable Business11:56 Creating Effective Standard Operating Procedures15:07 Building a Thriving Company Culture17:53 Growth Readiness and Business Sustainability Connect With Chad:Website: https://www.wellbuiltconsulting.com/ Support Titans of the Trades: If you found this episode insightful, please subscribe, share, and leave a review for Titans of the Trades. Your support goes a long way in helping us bring more impactful discussions your way.
Send us a comment!TODAY'S TREASUREEven though I walk through the valley of the shadow of death, I will fear no evil, for you are with me; your rod and your staff, they comfort me. Psalm 23:4 ESVSupport the show
Right About Now with Ryan AlfordJoin media personality and marketing expert Ryan Alford as he dives into dynamic conversations with top entrepreneurs, marketers, and influencers. "Right About Now" brings you actionable insights on business, marketing, and personal branding, helping you stay ahead in today's fast-paced digital world. Whether it's exploring how character and charisma can make millions or unveiling the strategies behind viral success, Ryan delivers a fresh perspective with every episode. Perfect for anyone looking to elevate their business game and unlock their full potential. Resources:Right About Now NewsletterFree Podcast Monetization CourseJoin The NetworkFollow Us On InstagramSubscribe To Our Youtube ChannelVibe Science MediaSUMMARYIn this episode of "Right About Now," hosted by Ryan Alford, guest Matt Higgins, CEO of RSE Ventures, shares his journey from poverty to success. The discussion centers on the concept of "burning the boats," symbolizing full commitment to one's goals without a backup plan. Matt emphasizes the importance of optimism, taking bold actions, and consistency in achieving success. He recounts his personal experiences, including his role in rebuilding the World Trade Center site and investing in drone technology. The episode highlights the significance of overcoming fear, recognizing opportunities, and maintaining a strong work ethic to achieve extraordinary outcomes.TAKEAWAYSBurning the Boats: The concept of fully committing to goals without a backup plan to enhance determination and effort.Personal Journey: Matt Higgins shares his background of overcoming poverty and making pivotal life decisions.Overcoming Fear and Anxiety: Discussion on how fear can hinder commitment and the importance of confronting internal obstacles.Role of Optimism: The significance of maintaining an optimistic mindset for recognizing opportunities and achieving success.Insights from Shark Tank: Experiences and lessons learned from participating in the television show, highlighting the work ethic of successful investors.Traits of Successful Investors: Key characteristics such as optimism, fearlessness, and strong work ethic that define successful investors.Importance of Commitment: The necessity of unwavering commitment to achieve goals and the mental barriers posed by backup plans.Consistency in Pursuing Goals: The value of persistence and tolerance for uncertainty in the journey toward long-term success.Overcoming Limitations: Encouragement to identify opportunities and envision potential despite perceived limitations.Future Aspirations: Optimism about the impact of technology on military operations and commitment to American innovation. If you enjoyed this episode and want to learn more, join Ryan's newsletter https://ryanalford.com/newsletter/ to get Ferrari level advice daily for FREE. Learn how to build a 7 figure business from your personal brand by signing up for a FREE introduction to personal branding https://ryanalford.com/personalbranding. Learn more by visiting our website at www.ryanisright.comSubscribe to our YouTube channel www.youtube.com/@RightAboutNowwithRyanAlford.
This week, in episode 225, Shawn Busse, Jennifer Kerhin, and Jaci Russo talk about how their businesses did this year and what they're planning for 2025. Jaci and Shawn have been surprised by a surge of new clients in December, which they say never happens. And Jennifer is excited because she's confident that in the first quarter she will finally exit the Valley of Death—that transitional period growing companies experience when the people and processes that made them successful stop working (AKA No Man's Land). Along the way, the owners discuss the relative merits of promoting from within vs. hiring from without, how long it should take to onboard senior-level hires, whether it's better to err on the side of budgeting for too little growth or too much, how they're training employees to use artificial intelligence, and what Jennifer can do to stop spending so much time writing and pricing proposals.
Qatar's sovereign wealth fund prepares for a petrodollar windfall, while oil majors scale back their $18bn power generation push. Israeli Prime Minister Benjamin Netanyahu begins testifying in a corruption trial, and public pension schemes and sovereign wealth funds plan to pour more money into private markets over the coming year. Mentioned in this podcast:Qatar's $500bn wealth fund targets bigger deals as LNG windfall looms BP and Shell rein in electricity ambitions to escape ‘valley of death' Benjamin Netanyahu arrives in court to testify in corruption trialPublic pension plans and wealth funds to invest more in private markets The FT News Briefing is produced by Niamh Rowe, Fiona Symon, Sonja Hutson, Kasia Broussalian and Marc Filippino. Additional help from Breen Turner, Sam Giovinco, Peter Barber, Michael Lello, David da Silva and Gavin Kallmann. Our engineer is Joseph Salcedo. Topher Forhecz is the FT's executive producer. The FT's global head of audio is Cheryl Brumley. The show's theme song is by Metaphor Music.Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.
Is Medicare a valley of death for medical innovation? While the U.S. is seen as a global leader in medical device innovation, the $800+ billion program that covers healthcare costs for senior citizens has been slow to reimburse certain medical devices, even when those devices are approved by the Food and Drug Administration. On average, it takes Medicare 4.5 years to cover a new FDA-approved medical device. This length of time has been dubbed the “Valley of Death,” referring to the human cost of delay. While members of Congress and advocates in the med tech industry are pushing Medicare to streamline its process, CMS, the Center for Medicare and Medicaid services, has sounded a note of caution, warning that moving too quickly fails to account for the unique needs and considerations of the Medicare population, Americans over 65 years old. Is this simply bureaucratic foot dragging, or are there legitimate safety and health risks with Medicare giving its blessing to new technologies and treatments? Is there a policy balance to be struck, where government health officials give seniors the unique consideration they need without denying them access to potentially life-saving treatments and devices?Evan is joined by Katie Meyer, Vice President of Public Affairs at Novacure, a global oncology company working to extend survival in some of the most aggressive forms of cancer. Prior to that, she served in Congress in various roles, including as Deputy Health Policy Director at the Senate Finance Committee.
This week, Ryan Connell is joined by Russ Long, founder and CEO of Long Capture, to talk about the different pathways to success a defense startup can take in the DoD. Russ shares his journey from his former Air Force contracting days to now helping tech startups bridge the gap to military adoption (a.k.a. surviving the Valley of Death.) They dive deep into the importance of impactful innovation, the evolving role of programs like SBIR, and how strategic and tactical financing are driving the second wave of defense innovation. Tune in to learn all about how to drive innovation in the defense acquisition process. TIMESTAMPS: (0:57) Russ's journey from contracting officer to CEO (1:55) What is “cool” technology? (2:55) The Benefits of SBIR and CSO Programs (5:47) How TACFI and STRATFI programs work (11:03) Do you have to be a commercial-first company to survive in DoD? (14:46) What is the second wave of defense Innovation? (19:49) Why sole source authority is critical (26:47) What Russ looks for in a startup (30:20) Free ways to learn from Long Capture LINKS: Follow Ryan: https://www.linkedin.com/in/ryan-connell-8413a03a/ Follow Russ: https://www.linkedin.com/in/russell-long/ Long Capture: https://longcapture.com/ Project Mercury: https://projectmercury.us/ CDAO: https://www.ai.mil/ Tradewinds: https://www.tradewindai.com/
All about defense. This is arguably one of the most difficult and interesting conversations we've ever had on the podcast. Enjoy the listen :) Timestamps (2:10) - What are Segundo Bros? (5:30) - What can young people do in Defense? (11:44) - $1000 drones taking out 3 billion dollar ships (25:20) - Deterrence Theory and Francis Fukuyama (40:50) - The Valley of Death for Defense Startups (55:00) - The Trickle Down Effect of Defense Tech
The band heads up into the mountains. There is an eerie silence lingering here. What could have caused it...?We're an actual play podcast where professional actors in Sweden play the best of Swedish RPGs. Led by one of Swedens most experienced and appreciated podcast game masters we play Dragonbane, a game published by Free League Publishing.Starring: Jakob Hultcrantz Hansson, Ingela Lundh, Mattias Redbo and special guest star Amanda StenbackGame Master: Andreas LundströmThe original music for Sweden Rolls by Andreas Lundström
Clean energy technologies saw a record influx of investment last year: $1.7 trillion in total. But that still falls short of what's needed to meet climate goals. With venture capital investment now falling, it's increasingly difficult for startups to gain traction. Claire Curry, global head of technology, industry & innovation at BloombergNEF, follows the journeys of many young companies in the clean-tech space. On this week's Zero, Curry tells Akshat Rathi about the kinds of innovative pathways that have proven successful. LanzaTech, for example, a nine-year-old carbon recycling technology company, works with Chinese steel companies looking for low-emissions solutions. H2 Green Steel also scaled quickly, in part through agreements reached with Mercedes Benz, IKEA and other big brands looking to access low-carbon steel. Curry explains how these approaches could be replicated by other startups. Listen to Zero's episode about green-iron startup Electra. Listen to Switched On's episodes on clean-energy investments and plastic recycling. Zero is a production of Bloomberg Green. Our producers are Mythili Rao, Magnus Henriksson, and Sommer Saadi. Special thanks this week to Kira Bindrim. Thoughts or suggestions? Email us at zeropod@bloomberg.net. For more coverage of climate change and solutions, visit https://www.bloomberg.com/green.See omnystudio.com/listener for privacy information.
Original Air Date: November 29, 1946Host: Andrew RhynesShow: The Lone RangerPhone: (707) 98 OTRDW (6-8739) Stars:• Brace Beemer (Lone Ranger)• John Todd (Tonto) Writer:• Fran Striker Producer:• George W. Trendle Music:• Ben Bonnell Exit music from: Roundup on the Prairie by Aaron Kenny https://bit.ly/3kTj0kK
The Inside Carolina On the Beat crew discusses the week's press availabilities for North Carolina ahead on the Tar Heel trip to Clemson to face the Tigers in Death Valley on Saturday afternoon. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices
© 2020-2026 Ivy Podcast Discovery LLC
